“My biggest concern on the internal rollout is that the UN is establishing an extremely risky and invasive technology without transparent consultation with staff. So far there’s no consideration that staff may not consent to this,” says Alexander Ray, a former communications officer at the United Nations Environment Programme (UNEP).

He believes the UN is rushing forward with its internal digital ID program without proper protections for employee privacy and security. The UN began rolling out its digital ID for employees in late 2020. The first phase of implementation started in June 2024. [Read More]

In this clip, Catherine Austin Fitts, former HUD Assistant Secretary, investment banker, and founder of the Solari Report, offers a stark assessment of modern American power.

She argues that Donald Trump’s role was not to oppose centralized control, but to make it acceptable to conservatives, and that no major political faction is resisting the buildout of what she describes as a nationwide “control grid.” [Read More]

Stuff the Covid OGs were saying in 2021. https://t.co/7MkOJFvqyy

— Edward Dowd (@DowdEdward) January 23, 2026

Last Friday, it was reported that a man in New Zealand suddenly began vomiting blood. It was discovered he had hundreds of blood clots and multiple organ failure, and may need a heart transplant. Medical staff have been unable to provide a diagnosis.

In the following, Dr. Philip McMillan provides a possible explanation of what’s really going on. Covid changed the rules – and we’re still pretending it didn’t, he says. [Read More]

PRO TIP: If your doctor is 'baffled,' get a new doctor. pic.twitter.com/LdThEsdQYe

— Chris Martenson (@chrismartenson) January 15, 2026

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) on Saturday approved Arcturus Therapeutics’s Kostaive (zapomeran, ARCT-154) self-amplifying sa-mRNA COVID-19 vaccine for individuals aged 18 years and older. 

Governments are not only ignoring concerns about mRNA injections but are authorising enhanced versions of these genetic products despite limited long-term safety data and unresolved questions about duration, biodistribution, and immune effects. [Read More]